Prometheus Biosciences Probability of Future Stock Price Finishing Over 117.52

RXDXDelisted Stock  USD 199.92  0.24  0.12%   
Prometheus Biosciences' future price is the expected price of Prometheus Biosciences instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Prometheus Biosciences performance during a given time horizon utilizing its historical volatility. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
  
Please specify Prometheus Biosciences' target price for which you would like Prometheus Biosciences odds to be computed.

Prometheus Biosciences Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Prometheus Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Prometheus Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Prometheus Biosciences is not yet fully synchronised with the market data
Prometheus Biosciences has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 6.81 M. Net Loss for the year was (141.75 M) with loss before overhead, payroll, taxes, and interest of (106.04 M).
Prometheus Biosciences currently holds about 95.96 M in cash with (123.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.35.
Over 81.0% of the company shares are owned by institutional investors

Prometheus Biosciences Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Prometheus Stock often depends not only on the future outlook of the current and potential Prometheus Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Prometheus Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding40.6 M
Cash And Short Term Investments695.8 M

Prometheus Biosciences Technical Analysis

Prometheus Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Prometheus Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Prometheus Biosciences. In general, you should focus on analyzing Prometheus Stock price patterns and their correlations with different microeconomic environments and drivers.

Prometheus Biosciences Predictive Forecast Models

Prometheus Biosciences' time-series forecasting models is one of many Prometheus Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Prometheus Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Prometheus Biosciences

Checking the ongoing alerts about Prometheus Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Prometheus Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Prometheus Biosciences is not yet fully synchronised with the market data
Prometheus Biosciences has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 6.81 M. Net Loss for the year was (141.75 M) with loss before overhead, payroll, taxes, and interest of (106.04 M).
Prometheus Biosciences currently holds about 95.96 M in cash with (123.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.35.
Over 81.0% of the company shares are owned by institutional investors
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Consideration for investing in Prometheus Stock

If you are still planning to invest in Prometheus Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Prometheus Biosciences' history and understand the potential risks before investing.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
CEOs Directory
Screen CEOs from public companies around the world
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.